229 Multiple choice questions
,Definition 1 of 229
1. oral DA agonists with food and told to notify their provider if the N/V persist or become
severe. Patients taking apomorphine may be pretreated with trimethobenzamide (Tigan), an
antiemetic.
2. orthostatic hypotension (dizziness, lightheadedness on standing) and advised to sit or lie
down if these occur. They should also be told to move slowly when sitting up or standing up.
3. movement disorders (tremor, dystonic movements, twitching) should be explained; if these
occur, patients should notify their provider.
4. hallucinations; , and instruct them to notify you if these develop.
5. sleep attacks. If they occur, pts should avoid potentially hazardous activities (e.g., driving)
until they can be adequately managed.
6. ropinirole
Patient Education Antiseizure Drugs
1. Explain that finding the optimal dose takes time and
2. Inform patients about the dangers of abrupt
3. Advise patients who are planning a trip to
4. Explain the need to obtain refills on time so
5. Teach the patient (or a family member) to maintain
Patient Education with progestin-only contraception
1. taking the pill at the same time every day is important to their effectiveness for
instance,
2. progestin-only OCs are taken continuously. Use is initiated on
If one or more doses is missed or taken greater than 3 hours after the scheduled dose,
the following guidelines apply:
3. If one pill is missed, it should be taken as soon as remembered and 4. If two pills are
missed, the regimen should be restarted and backup contraception should be used
Summary of Key Prescribing Considerations Levodopa Combinations
1. Therapeutic Goal: To maintain or improve the patient's ability
2. Baseline Data: HR & BP and general cardiovascular (especially if apomorphine or
cabergoline are being considered) and neuro/motor assessment. ie:
3. Monitoring: Orthostatic VS must be assessed at each
4. Identifying High-Risk Patients: Caution must be exercised in dealing with patients who
have
Patient Education Dopamine Agonists
1. Patients should be informed that N/V can be reduced by taking
2. Pts should be informed about sxs of
3. The potential for
4. Forewarn patients that DA agonists can cause (blank) especially in older adults
5. Pts should also be aware that pramipexole, ropinirole, rotigotine, and apomorphine
, can cause
6. Patients of childbearing age should know that (blank) may harm the developing fetus
and advised to use effective birth control.
Definition 2 of 229
1. Alprostadil has the same chemical structure as prostaglandin E1, which causes vasodilation
When injected into the Intracavernous penile tissue it causes relaxation of smooth muscle
(arterial, venous, and trabecular), causing a rapid inflow of arterial blood.
The blood fills the vascular sinusoidal spaces of the corpus cavernosum, resulting in an
erection
Generalized Anxiety Disorder
1. is characterized as a
2. Most patients with GAD also have
3. GAD should not be confused with situational anxiety,
Cluster Headaches
1. cluster headaches differ in several ways:
2. Drug Therapy is directed at
3. 1st line therapy is
4. Abortive therapy can be achieved with
1. Tx goals for AD
2. No single drug is more effective than the others, so
3. The current gold standard of treatment for cognitive symptoms
1. Preferred administration route of alprostadil and why
Because of the inconvenient method of dosing, these drugs are second-line agents for
ED.
, Definition 3 of 229
1. children, adolescents, and adults <25 years.
2. pts on antidepressant drugs should be observed closely for suicidality, worsening mood,
and unusual changes in behavior.
3. the first few months of therapy and whenever antidepressant dosage is changed (incrd OR
decrd).
4. The patient or caregiver should meet with the prescriber at least weekly during the first 4
weeks of treatment, then biweekly for the next 4 weeks, then once 1 month later, and
periodically thereafter. Phone contact may be appropriate between visits.
5. monitor the pt daily, for decline: (anxiety, agitation, panic attacks, insomnia, irritability,
hostility, impulsivity, hypomania, and, of course, emergence of suicidality). If these symptoms
are severe or develop abruptly, the patient should see his or her prescriber immediately.
Summary of Key Prescribing Considerations Triptans
1. Therapeutic Goal: Termination of
2. Baseline Data: Assess for possible underlying
3. Monitoring: No
4. Identifying High-Risk Patients: All triptans are contraindicated for
5. Evaluating Therapeutic Effects: Determine the size and frequency
6. Minimizing Adverse Effects: Sumatriptan can cause
Suicide Risks and Considerations Safety measures
1. Concerns about antidepressant-induced suicide apply mainly to
2. To reduce the risk for suicide,
3. Close observation is especially important during
4. Ideally,
5. In addition, family members or caregivers should
Summary of Key Prescribing Considerations-Progestins
1. Therapeutic Goal: Goals for noncontraceptive uses are to counteract
2. Baseline Data: Heart rate, blood pressure, and weight.
3. Monitoring: Blood pressure. Assessment for fluid retention, including weight. Consider
referral for
4. Identifying High-Risk Patients: Progestins are contraindicated in the presence of
5. Minimizing Adverse Effects: Progestins can cause breakthrough bleeding, spotting,
and amenorrhea. Warn patients that
Administration methods for transdermal preparations
1. Testosterone is available in three transdermal formulations:
2. patches (Androderm) are indicated for
3. the gels have three advantages over patches: they
4. Black Box Warning-Testosterone Gel and Topical Solution
5. Why is secondary exposure a problem with gels?